Before you continue

LivingLabs.Blog is for learning — not medical advice. Some peptides we cover are research compounds and aren't FDA-approved. Always talk to a qualified healthcare provider before starting anything. Everyone reacts differently, and we don't sell peptides or recommend vendors.

We use cookies to understand how the site is used and improve it. See how we handle your data in our privacy practices.

Home / Blogs / Blog / BPC-157 and Potential Anhedonia

Back to Blog

Blog 1 min read June 6, 2026

Twitter / X
Facebook
LinkedIn
Email

BPC-157 and Potential Anhedonia

A user beginning a BPC-157 cycle for injury repair expressed concern regarding potential side effects. They reported observing anecdotal evidence from others suggesting the peptide may cause anhedonia.

Dosing guides

Single peptides
Blends
Stacks
All dosing guides

Resources

How to mix a peptide
Dose calculator
Articles
Common questions
Starter Guide
Injection 101
How to Use This Site

Join the list

New research, dosing tips, and easy-to-read guides — sent straight to your inbox.

No spam, ever. Unsubscribe whenever you like.

A quick heads-up

Everything on LivingLabs.Blog is for learning — not medical advice. Some peptides we cover are research compounds and aren't FDA-approved. Always talk to a qualified healthcare provider before starting anything. Everyone reacts differently. We don't sell peptides or recommend vendors.

We cite peer-reviewed research wherever we can.